HRA Pharma works with BallouPR on emergency contraceptive

HRA Pharma is working with BallouPR on Ella, the emergency contraceptive currently under review by the Food and Drug Administration (FDA).

HRA Pharma is working with BallouPR on Ella, the emergency contraceptive currently under review by the Food and Drug Administration (FDA).

Last week, an FDA advisory committee said that the drug, ulipristal acetate, is safe and effective. The drug can prevent pregnancy if taken up to five days after unprotected sex. The company is seeking approval for the drug, which would need to be prescribed.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.